Proximal shift of colorectal cancer. A persistent phenomenon with multiple causes, patterns and clinical implications

Journal of B.U.ON.

Volumn 19, Issue 3, 2014, Pages 605-617

  Papagiorgis, Pedros C ^a   Oikonomakis, Ioannis ^b   Delaportas, Dionysius ^c   Myoteri, Despoina ^d   Arkoumani, Elissavet ^d   Thalassinos, Nikolaos ^a   Zizi Sermpetzoglou, Adamantia ^d  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Colorectal cancer; Epidemiology; Proximal shift

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ASCENDING COLON; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SCREENING; CECUM; CHOLECYSTECTOMY; COLONOSCOPY; COLORECTAL CANCER; DEMOGRAPHY; DESCENDING COLON; DIABETES MELLITUS; DIETARY INTAKE; DRINKING BEHAVIOR; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PHYSICAL INACTIVITY; RECTUM; REVIEW; SIGMOID; SMOKING; TRANSVERSE COLON; AGE; CANCER STAGING; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; GENETIC PREDISPOSITION; LIFESTYLE; SEX DIFFERENCE;

AGE FACTORS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; NEOPLASM STAGING; SEX FACTORS;

EID: 84908402146     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Nawa T, Kato J, Kawamoto H et al. Differences between right and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 2008;23: 418-423.
2. Benedix F, Kube R, Meyer F et al. Comparison of 17, 641 patients with right-and left-sided colon cancer: Differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53: 57-64.
3. Ghazi S, Lindforss U, Lindberg G, Berg E, Lindblom A, Papadogiannakis N. Analysis of colorectal cancer morphology in relation to sex, age, location and family history. J Gastroenterol 2012;47: 619-634.
4. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopet-ta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in CRC Lancet 2000;355: 1745-1750.
5. Russo A, Bazan V, Iacopetta D, Kerr D, Soussi T, Geb-bia N. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutatiominfluence of tumor site, type of mutation, and adjuvant treatment J Clin Oncol 2005;23: 7518-7528.
6. Iacopetta B. Are there two sites to colorectal cancer? Int J Cancer 2002;101: 403-408.
7. Carethers J. One colon lumen but two organs. Gastroenterology 2011;141: 411-412.
8. Potter J. Colorectal caneen Molecules and populations. J Natl Cancer Inst 1999;91: 916-932.
9. Obrand DI, Gordon PH. Continued change in the distribution of colorectal carcinoma. Br J Surg 1998;85: 246-248.
10. Chauvenet M, Cottet V. Lepage C, Jooste V, Faivre J, Bouvier M. Trends in colorectal cancer incidences period and birth-cohort analysis in a well-defined French population. BMC Cancer 2011;11: 282.
11. Shah A, Sarfati D, Blakely T, Atkinson J, Dennett E. Trends in colorectal cancer incidence rates in New Zealand, 1981-2004. ANZ J Surg 2012;82: 258-264.
12. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Bio-markers Prev 2012;21: 411-416.
13. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 2003;98: 1400-1409.
14. Gupta A, Melton J, Petersen G et al. Changing trends in incidence, stage, survival and screen-detection of colorectal caneen a population-based study. Clin Gastroenterol Hepatol 2005;3: 150-158.
15. Saltzstein S, Behling C. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: A study of 213, 383 cases from the California Cancer Registry. J Clin Gastroenterol 2007;41: 173-177.
16. Gao N-R, Neutel I, Wai E. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health 2008;30: 194-201.
17. Vassilopoulos P, Kelessis N, Plataniotis G, Gondikakis E, Galanos A. Colorectal cancer trends by anatomic sides, age and staging. A twenty-year study of 1412 Greek cases. Anticancer Res 2000;20: 4773-4776.
18. Ponz de Leon M, Marino M, Benatti P et al. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 2004;15: 940-946.
19. Gomez D, Dalai Z, Raw E, Roberts C, Lyndon PJ. Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: Is there a true "rightward shift"? Postgrad Med J 2004;80: 667-669.
20. Nelson RL, Persky V, Turyk M. Determination of factors responsible for the declining incidence of colorectal cancer. Dis Colon Rectum 1999;42: 741-752.
21. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev 2006;15: 792-797.
22. Rozen P, Liphshitz I, Barchana M. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur J Cancer Prev 2011: 20: 46-53.
23. Meza R, Jeon J, Renehan A, Luebeck G. Colorectal cancer incidence trends in the US and UK: Evidence of right-to left-sided biological gradients with implication for screening. Cancer Res 2010;70: 5419-5429.
24. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol 2009;39: 189-191.
25. Sarli L, Michiara M, Sgargi P et al. The changing distribution and survival of colorectal carcinoma: An epidemiological study in an area of northern Italy. Eur J Gastroenterol Hepatol 2005;17: 567-572.
26. Wessler J, Pashayan N, Greenberg D, Duffy S. Age-period-cohort analysis of colorectal caner in East Anglia, 1971-2005. Cancer Epidemiol 2010;34: 232-237.
27. Devesa S, Chow W-H. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993;71: 3819-3826.
28. Mostafa G, Matthews B, Norton H, Kercher K, Sing RF, Heniford B. Influence of demographics on colorectal cancer. Am Surg 2004;70: 259-264.
29. Beart RW, Melton LJ 3rd, Manata M, Docker-ty MB, Frydenberg HB, O'Fallon WM. Trends in right and left-sided colon cancer. Dis Colon Rectum 1983;26: 393-398.
30. Nelson-Snyder D, Heston JF, Meigs W, Flannery JT. Changes in site distribution of colorectal carcinoma in Connecticut, 1940-1973. Digest Dis 1977;22: 791-797.
31. Boland CR, Savides TJ. The changing scope of colorectal cancer. Gut 2001;49: 449-450.
32. Levi F, Randimbison L, La Vecchia C Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry. Cancer 1993;72: 46-50.
33. Gonzalez EC, Roetzheim RG, Ferrante JM, Campell R. Predictors of proximal vs distal colorectal cancers. Dis Colon Rectum 2001;44: 251-258.
34. Canadian Partnership Against Cancer. Colorectal cancer incidence and mortality. Cancer Control Snapshot 2 2010 Nov; www.cancerview.ca/idc/groups/public/documents/webcontent/rl-crc-snapshot-two-en.pdf.
35. Cheng L, Eng C Nieman LZ, Kapadia AS, Du LX Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 2011;34: 573-580.
36. Murphy G, Devesa S, Cross A, Inskip P, McGlynn K, Cook M. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer 2011;128: 1668-1675.
37. Wong R. Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med 2010;25: 1157-1163.
38. Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB. Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 2009;20: 4542-4547.
39. Newcomb PA, Zheng Y, Chia VM et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007;67: 7534-7539.
40. Raut CP, Pawlick TM, Rodriguez-Bigas A. Clinico-pathologic features in colorectal cancer patients with microsatellite instability. Mutation Res 2004;58: 275-282.
41. Oh S-W, Kim YH, Choi YS et al. The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum 2008;51: 56-61.
42. Cooper K, Squires H, Karroll C et al. Chemoprevention of colorectal cancer: Systematic review and economic evaluation. Health Technol Assess 2010;14: 1-26.
43. Zisman A, Nickolov A, Brand R, Gorchow A, Roy H. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco. Arch Intern Med 2006;166: 629-654.
44. Center M, Jemal A, Smith R, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009;59: 566-378.
45. West DW, Slattery ML, Robison LM et al. Dietary intake and colon cancersex -and anatomic site-specific associations. Am J Epidemiol 1989;130: 883-894.
46. Moradi T, Gridley G, Bjork J et al. Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic sub-site. Eur J Cancer Prev 2008;17: 201-208.
47. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002;31: 925-943.
48. Annema N, Heyworth JS, McNaughton SA, Iacopetta B, Fritschi L Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia. J Am Diet Assoc 2011;111: 1479-1490.
49. Edwards BK, Ward E, Kohler BA et al. Annual report to the nation on the status cancer, 1975-2006, featuring colorectal cancers trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116: 544-573.
50. Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: An interpretation of the temporal patterns by anatomic subsite. Int J Cancer 2010;126: 721-732.
51. McMichael AJ, Potter JD. Host factors in carcinogenesis: Certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985;75: 185-191.
52. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005;100: 1813-1820.
53. Limburg P, Anderson K, Johnson T et al. Diabetes mellitus and subsite - specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14: 133-137.
54. Limburg P, Vierkant R, Fredericksen Z et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer riska population-based, retrospective cohort study. Am J Gastroenterol 2006;101: 1872-1879.
55. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011;106: 1340-1550.
56. Nasir A, Lopez A, Boulware D, Malafa M, Coppola D. Correlation between COX-2 and APC expression in left versus right-sided human colon cancer. Anticancer Res 2011;51: 2191-2195.
57. Slattery M, Murtaugh M, Quesenberry C, Caan B, Edwards S, Sweeney C Epidemiologic perspectives and innovations. Epidemiol Perspect Innov 2007;4: 10, doi: 10.1186/1742-5575-4-10.
58. Vasen HFA, Moslein G, Alonso A et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Familiar Cancer 2010;9: 109-115.
59. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familiar relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 2004;55: 1522-1328.
60. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L Rates of new or missed colorectal cancers after colonoscopy and their risk factors. A population-based analysis. Gastroenterology 2007, 152: 96-102.
61. Lakoff J, Paszat L, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopyiA population-based study. Clin Gastroenterol Hepatol 2008;6: 1117-1121.
62. Kaku E, Oda Y, Murakami Y et al. Proportion of flat -and depressed- type and laterally spreading tumor among advanced colorectal neoplasia. Clin Gastroenterol Hepatol 2011;9: 503-508.
63. Okamoto M, Kawabe T, Yamaji Y et al. Flat-type early colorectal cancer preferentially develops in right-sided colon in older patients. Dis Colon Rectum 2005;48: 101-107.
64. Baxter N, Warren J, Barrett M, Stukel T, Doria-Rose V. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012;30: 2664-2669.
65. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: A population-based, case-control study. Ann Intern Med 2011;154: 22-30.
66. Greystoke A, Mullamitha SA. How many diseases are colorectal cancer? Gastroenterol Res and Pract 2012 Sep; 2012 www.ncbi.nlm.nih.gov/pubmed/7t.er-m=greystoke+mullamitha doi: 10.1155/2012/564741.
67. Axtell L, Chiazze L Changing relative frequency of cancers of the colon and rectum in the United States. Cancer 1966;19: 750-754.
68. Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 2005;11: 4685-4688.
69. Stang A, Stabenow R, Stegmaier C, Eisinger B, Bischof-Hammes E, Jockel Karl-Heinz. Unexplained inversion of the incidence ratio of colon and rectal cancer among men in East Germany. A time trend analysis including 147, 790 cases. Eur J Epidemiol 2007;22: 245-255.
70. Erkek B, Ozkan N, Bayar S et al. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases. Hepatogastro-enterology 2007;54: 77-80.
71. Fuszek P, Horvath H, Speer G et al. Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need of a colorectal cancer screening program in Hungary. Anticancer Res 2006;26: 527-532.
72. Papagiorgis P, Zizi-Sermpetzoglou A, Tseleni S, Oikonomakis IN, Sofras L, Nikiteas NI. Worse histological grade of proximal colorectal tumors and its relation with stage. JBUON 2012;17: 79-84.
73. Basdanis G, Mekras A, Papadopoulos VN et al. A retrospective analysis of 2000 cases with colorectal cancer. Tech Coloproctol 2011;15 (Suppl 1): S107-110.
74. Efremidou EI, Lireatzopoulos N, Papageorgiou SM et al. Colorectal carcinoma: Correlation between age, gender and subsite distribution. Chirurgia (Bucur) 2008;103: 659-663.
75. Pappas AV, Lagoudianakis EE, Dallianoudis IG et al. Differences in colorectal cancer patterns between right and left sided colorectal cancer lesions. JBUON 2010;15: 509-513.
76. Tentes AA, Korakianitis O, Kakolyris S et al. Differences between right- and left-sided colon carcinomas. JBUON 2010; 15: 285-289.
77. Patel S, Nelson R, Sanchez J et al. Elderly patients with colon cancer have unique tumor characteristics and poor survival. Cancer 2013;119: 739-747.
78. Hemminki K, Santi I, Weires M, Thomsen H, Sund-quist J, Bermejo JL. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 2010: 10: 688.
79. McCowan CI, Munro AJ, Donnan PT, Steele RJ. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. Eur J Cancer 2013;49: 1049-1057.